Form 8-K - Current report:
SEC Accession No. 0001654954-20-013396
Filing Date
2020-12-10
Accepted
2020-12-10 16:48:45
Documents
7
Period of Report
2020-12-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT aytu_8k.htm 8-K 31545
2 CONSENT OF RSM US LLP aytu_ex231.htm EX-23.1 3641
3 AUDITED FINANCIAL STATEMENTS OF NEOS THERAPEUTICS, INC. AS OF AND FOR THE YEARS aytu_ex991.htm EX-99.1 1979089
4 UNAUDITED FINANCIAL STATEMENTS OF NEOS THERAPEUTICS, INC. AS OF AND FOR THE THRE aytu_ex992.htm EX-99.2 992780
5 UNAUDITED FINANCIAL STATEMENTS OF NEOS THERAPEUTICS, INC. AS OF AND FOR THE THRE aytu_ex993.htm EX-99.3 984504
6 UNAUDITED FINANCIAL STATEMENTS OF NEOS THERAPEUTICS, INC. AS OF AND FOR THE THRE aytu_ex994.htm EX-99.4 843784
7 UNAUDITED PRO FORMA aytu_ex995.htm EX-99.5 529749
  Complete submission text file 0001654954-20-013396.txt   5366334
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOSCIENCE, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 201381164
SIC: 2834 Pharmaceutical Preparations